Loading organizations...
§ Venture Capital · Bahnhofstrasse 1, Altendorf, Schwyz, 8852, Switzerland
VI Partners is a company.
VI Partners operates as a venture capital firm, specializing in backing exceptional entrepreneurs across the healthcare and technology sectors within Switzerland and broader Europe. The firm provides strategic investment and support, focusing on companies that are developing solutions to significant societal and industrial challenges. Its approach centers on empowering innovation by partnering with visionary individuals dedicated to building impactful, industry-leading companies from early stages.
The firm was established over two decades ago, in 2001, with an initial mandate to promote innovation and foster entrepreneurship within the Swiss economy. This foundational insight drove the creation of a platform designed to identify and cultivate promising ventures that possess the potential for substantial market influence. Over its history, VI Partners has evolved to partner with a diverse range of companies, emphasizing long-term growth and sustained impact.
VI Partners targets outstanding individuals and their companies throughout Switzerland and Europe. Its mission is to fuel brighter futures by investing in these entrepreneurs, supporting their efforts to solve pressing challenges and create a better tomorrow. The firm's long-term vision positions it as a leading technology and healthcare investor, aiming to be the preferred partner for innovative companies with global ambitions.
Key people at VI Partners.
VI Partners was founded in 2001 by Arnd Kaltofen (Co-Founder and Managing Partner) and Alain Nicod (Co-Founder and Managing Partner).
VI Partners is a Swiss venture capital firm founded in 2001, specializing in early-stage investments in Healthcare (Life Sciences, biotech, medtech) and Technology (ICT, fintech, data science, retail tech) sectors, primarily across Europe including Switzerland, Germany, France, UK, and Austria.[1][3][5] With over 20 years of expertise, the firm has invested in more than 66 startups totaling over CHF 330 million, emphasizing a data-driven strategy that pairs capital with coaching, networks, and operational support to drive growth in university spin-offs and innovative teams.[1][2][4][5] Its mission focuses on empowering disruptive innovations, evidenced by notable exits like Nexthink ($3B valuation), Oculis (Nasdaq IPO), and Araris Biotech (acquired by Taiho for $400M+).[3][5]
VI Partners traces its roots to 2000, when its founding team advised Venture Incubator, an initiative by ETH Zurich (a leading science and technology university) alongside McKinsey & Company and ten blue-chip Swiss companies.[4][5] Formally established in 2001, it became Switzerland's longest-standing VC firm dedicated to early-stage Life Science and Technology investments.[3] Key figures include founder and senior advisor Alain Nicod, managing partner Arnd Kaltofen, operating partner Cyrill Osterwalder, and venture partner Daniel Gutenberg.[6] The firm's focus has evolved from advising incubators to managing funds and direct investments, completing over 50 deals with 26 exits, while expanding into growth-stage opportunities across Europe and North America.[1][4]
VI Partners rides the wave of European deep tech resurgence, particularly in AI-driven healthcare (e.g., Vara's breast-imaging AI, Kadoa's unstructured data agents) and industrial tech (Almer's AR headsets acquired by RealWear), amid radiologist shortages and AR market growth.[3][5] Timing aligns with Europe's push for sovereign AI and biotech innovation post-2020s funding boom, fueled by ETH Zurich's spin-off ecosystem and cross-border talent flows.[2][4] Market forces like aging populations boosting medtech demand and AI adoption in finance/health favor its portfolio, while VI influences the ecosystem by bridging academia (ETH) to scale-ups, enabling exits that validate Swiss innovation globally.[1][5]
VI Partners is poised to capitalize on AI-healthcare convergence and cleantech, with recent 2025 leads in Kadoa signaling deeper agentic AI bets amid Europe's $100B+ VC resurgence.[3][5] Trends like regulatory tailwinds for AI diagnostics (Vara's EU authorization) and industrial AR will shape its trajectory, potentially driving more unicorns via its ETH-McKinsey network.[5] Its influence may evolve toward larger funds and US expansion, sustaining Switzerland's VC leadership—echoing its origin as the incubator for Europe's next tech pioneers.[1][4]
VI Partners was founded in 2001 by Arnd Kaltofen (Co-Founder and Managing Partner) and Alain Nicod (Co-Founder and Managing Partner).
Key people at VI Partners.
VI Partners has more than 26 tracked investments across 18 companies. The latest tracked deal is $11.7M Series A in Somagenetix in October 2024.
